Published by Josh White on 12th August 2021
(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Thursday, with Korea Pharma in South Korea.
URL: http://www.digitallook.com/dl/news/story/32053154/...